Andrea Gardiner
Investor at Gelomics
Andrea Gardiner
Investor at Gelomics
New South Wales
Overview
Work Experience
Founder, CEO and Chief Investment Officer
2015 - Current
Jelix is a venture capital funds manager based in Sydney. Jelix backs daring founders to make the world better. Our investment focus is on early stage tech companies, where the technology is truly innovative and provides a strong competitive advantage in a huge market, usually global, and is operated by high calibre founders. Jelix has $50m under management comprised of a $30m fund and $20m in syndicated investments. Jelix has an aggregate of 36 portfolio companies (18 in fund 1 & 34 in syndicated investments including overlaps). Jelix Syndicated investments Invest in world class Australian tech startups with sector insiders. Jelix founders invest their own funds in young innovative companies and invite investors to co-invest with us on the same terms. We leverage our unique deal flow and expertise in the sector, to select the strongest investment opportunities; companies in the strongest position to produce outstanding returns. We invest in 6-8 companies p.a. out of 1,600 applications we screen with Innovation Bay. We further mitigate risk with meticulous due diligence, structuring terms to best position the company for growth and providing ongoing access to our networks and expertise. Angel Investors Innovation is exciting and can produce outstanding returns. Be part of it. Build your portfolio with confidence and support the Australian economy • gain unique access to pre-vetted, stand out, early stage investment opportunities • save time, let us do the work for you • gain confidence investing alongside experienced angel investors and trusted venture capital funds • secure follow on investment rights Entrepreneurs Take the pain out of fundraising and focus on building your business • gain unique access to 500 registered angel investors • smart money: leverage our entrepreneurial expertise & connections and that of our angels & VCs • save time and money with an easy fundraising process, allowing you to focus on realising your vision • no fees
Non-Executive Board Director / Investor
2023
Gelomics pioneers ethical drug development with advanced human tissue engineering. It accelerates drug development by enabling pharmaceutical companies to grow human tissues in a petri dish as an alternative to animal experiments.
Non-Executive Board Director / Investor
2022
Ai/machine learning and vision recognition technology-optimising in-person retail experiences with spatial AI
Non Executive Board Director / Investor
2021
Cutting-edge AI crop analysis technology helping growers manage crops and increasing accuracy of crop predictions
Non-Executive Board Director / Investor
2018
Sinorbis makes it easy for Western companies to have a digital presence in China.
Board Member
2013
A US company managing US$40m property portfolio • Active in decision making in oversight of good management.
Angel Investor, Investor
2002
25 investments into 18 technology startups including: -10 x return in 3.5 years for our investors in StorReduce! -leading Series A investment into Sinorbis, raising $2.5m our of $4m raise -co-investment into Inquisitive with Airtree Ventures and Skip Capital
Investor Board director
2023 - 2024
Clipboard is an Extracurricular Management System (EMS), designed to help schools manage all activities outside the classroom with ease.
Non-Executive Board Director / Investor
2021 - 2022
Online cybersecurity education for software developers
Non-Executive Board Director / Investor
2016 - 2019
Cutting edge mixed reality / social media platform with outdoor geolocation and tagging.
Education
Law Society Final Examinations
1991 - 1992